Second Person to Receive Pig Heart Dies Six Weeks After Transplant
By Physician’s Briefing Staff HealthDay Reporter
WEDNESDAY, Nov. 1, 2023 – The second person to ever receive a transplanted pig heart has died.
Lawrence Faucette, 58, got the transplant just six weeks earlier at the University of Maryland Medical Center in an experimental procedure. Unfortunately, the heart had been showing signs of rejection in the days before his death, CNN reported.
Bartley Griffith, M.D., clinical director of the Cardiac Xenotransplantation Program at the University of Maryland School of Medicine in Baltimore, performed the transplant.
"Mr. Faucette's last wish was for us to make the most of what we have learned from our experience, so others may be guaranteed a chance for a new heart when a human organ is unavailable. He then told the team of doctors and nurses who gathered around him that he loved us. We will miss him tremendously," Griffith told CNN.
Faucette received the transplant on Sept. 20, six days after having symptoms of heart failure. He had been ineligible for a human heart because of his heart disease and preexisting conditions. Faucette had been making significant progress after the transplant. Doctors said a month after his surgery that Faucette's heart function was excellent, CNN reported. Faucette had also received an experimental antibody treatment to help prevent rejection of the heart.
The University of Maryland team also performed the first experimental pig heart transplant, that time on David Bennett, 57, in January 2022. Bennett died two months later from "a complex array of factors," including his condition prior to surgery.
CNN Article
Source: HealthDay
Posted : 2023-11-02 06:52
Read more
- Specific Pesticides Linked to Increased Risk for Rheumatoid Arthritis
- ASH: Reduced-Dose Anticoagulants Not Noninferior for Recurrent VTE
- Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007
- Reported Use of Most Drugs Among Adolescents Remained Low in 2024
- Children Have Various Symptoms Within Five Years Before MS Diagnosis
- Could AI Plus Lasers Help Catch Very Early Breast Cancers?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions